www.neurologiepropraxi.cz / Neurol. praxi. 2023;24(6):453-457 / NEUROLOGIE PRO PRAXI 457 PŘEHLEDOVÉ ČLÁNKY Migréna a roztroušená skleróza LITERATURA 1. Kister I, Caminero AB, Monteith TS, et al. Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain. 2010;11(5):417-425. 2. Putzki N, Pfriem A, Limonroth V, et al. Prevalence of migraine, tension‑type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol. 2009;16:262-267. 3. Moisset X, Ouchchane L, Guy N, et al. Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain. 2013; 154:2691-2699. 4. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for Eurolight project. J Headache Pain. 2010; 11(4):289-299. 5. Flachenecker P, Stuke K, Elias W, et al. Multiple sclerosis registry in Germany: results of extension phase phase 2005/2006. Dtsch Artztebl. 2008;105(7):113-119. 6. Gebhardt M, Kropp P, Jurgens TP, et al. Headache in the first manifestation of multiple sclerosis – prospective, multicenter study. Brain Behav. 2017;7(12):e00852. https://doi. org/10.1002/brb3.852. 7. Gebhardt M, Kropp P, Hoffmann F, et al. Kopfschmerzen bei Multiplex Sklerose. Nervenartzt. 2020;91(10):926-935. 8. Saberi A. Migraine headache in Multiple Sclerosis. Is more frequent among MS patients? Romanian journal of neurology. 2023;22(1):54-57. 9. Kister I, Caminero A, Herbert J, et al. Tension‑type headache and migraine in multiple sclerosis. Curr Pain Headache Rep. 2010;14:441-448. 10. Mijajlovic MD, Aleksic VM, Covickovic, et al. Cluster headache as a first manifestation of multiple sclerosis: case report and literature review. Neuropsychiatr Dis Treat. 2014; 10:2269-2274. 11. Montano N, Rapisarda A. The role of neurovascular conflict in patients with multiple sclerosis and trigeminal neuralgia. Cephalalgia. 2021;41(13):1409-1410. 12. Husain F, Pardo G, Rabadi M. Headache and Its Management in Patients With Multiple Sclerosis. Curr Treat Options Neurol. 2018;20:10. DOI 10.1007/s11940-018-0495-4. 13. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996;47:52-59. 14. Rosali G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117-139. 15. Kister I, Munger KL, Herbert J, et al. Increased risk of multiple sclerosis among women with migraine in the nurses health study II. Mult Scler. 2012;18(1):90-97. 16. Mariotti P, Nociti V, Stefanini MC, et al. Chronic migraine ‑like headache caused by a demyelinating lesion in the brain stem. Pain Med. 2012;13(4):610-612. 17. Elmazny A, Hamdy SM, Abdel‑Naseer M, et al. Interferon ‑beta induced headache in patients with multiple sclerosis: frequency and characterization. J. Pain Re.s 2020;13:537-545. http://doi.org/10.2147/JPR.S230680. 18. Naktsuji Y, Nakano M, Moriya M, et al. Beneficial effect of interferon‑beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon‑beta injection. Cytokine. 2006;15(1-2):69-74. 19. Polman C, O’Connor P, Havrdova E, et al. A randomized, placebo‑controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354(9):899-910. 20. CAMMS 223 Trial Investigators. Alemtuzumab vs. interferon beta!-a in early multiple sclerosis. N Engl J Med. 2008; 359(17):1786-1801. 21. Gee JR, Chang J, Dublin AB, et al. The association of brainstem lesions with migraine‑like headache: an imaging study of multiple sclerosis. Headache. 2005;45(6):670-677. 22. Merkler D, Klinker F, Jurgens T, et al. Propagation of spreading depression inversely correlates with cortical myelin content. Ann Neurol. 2009;66(3):355-365. 23. Conti P, D’Ovidio C, Conti C, et al. Progression in migraine: role of mast cells and pro‑inflammatory and anti‑inflammatory cytokines. Eur J Pharmacol. 2019;844:87-94. http://doi.org/10.1016/j. ejphar.2018. 12. 004. 24. Munno I, Marinaro M, Bassi A, et al. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache. 2001;41:764-767. 25. Magliozzi R, Howell O, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010;477-493. 26. Bracci‑Laudiero L, Aloe L, Buanne P, et al. NGF modulates CGRP synthesis in human B‑lymphocytes: a possible anti‑inflammatory action of NGF? J Neuroimmunol. 2002; 123(1-2):58-65. 27. Klein M, Woehrl B, Zeller G, et al. Stabbing headache as a sign of relapses in multiple sclerosis. Hedache. 2013;53:1159-1161. 28. Granberg T, Martola J, Kristoffersen‑Wiberg M, et al. Radiologically isolated syndrome‑incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler. 2013;19(3):271-280. 29. Kantarci OH, Lebrum C, Siva A, et al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol. 2016;79(2):288-294. 30. Okuda DT, Kantarci O, Lebrun‑Frenay C, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023;93(3):604-614. doi: 10.1002/ ana.26555. Epub 2022 Dec 10. PMID: 36401339. ČESKÝ A SLOVENSKÝ NEUROLOGICKÝ SJEZD 37. 27.–29. 11. 2024 | CLARION CONGRESS HOTEL OSTRAVA Těšíme se na setkání s Vámi v listopadu 2024 v Ostravě! www.registrace-solen.cz
RkJQdWJsaXNoZXIy NDA4Mjc=